CFD service Plus500 seems to be on a roll over the past few weeks as it continues to introduce new assets that are accessible on their platforms.
One of the latest additions is the Cronos Group which are now available on the cannabis shares section.
Look:
Since the beginning of 2019, the company’s value has already doubled and currently, this is among the largest publicly traded marijuana stocks.
With the increasing number of nations waving the green flag on medical cannabis, the marijuana industry is budding poised for growth and this could open the door to billions of dollars in revenue for the market once the industry is fully ramped up.
The Cannabis Act has legalized recreational cannabis use nationwide in Canada trigerring investors to look for pot stocks which are now receiving a lot of hype and gone through wild swings.
International push is on track
With Canada legalizing marijuana, Cronos is looking to supply more cannabis products not only on the domestic market but in other countries where medical weed has been legalized.
In fact, its subsidiary in Australia has been given a manufacturing license for medical cannabis and the company has also made distribution partnership with Delfarma, a pharmaceutical wholesaler in Poland.
Plus500 Cronos Group Cannabis shares
*Illustrative prices only
Why Trade Cannabis Shares with Plus500?
Trading with this CFD service has a lot of benefits:
• No commissions
• Authorised and regulated
• Simple and intuitive platform
• Competitive Spreads
So, do you think that Cronos is the next big trading opportunity? Invest on this smoking-hot shares right now with the leading CFD trading platform.
84% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you can afford to take the high risk of losing your money
